Trastuzumab
#
Find similar titles
- (rev. 3)
- Hyungyong Kim
Structured data
Trastuzumab (INN; trade names Herclon, Herceptin) is a Monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain Breast cancers.
Table of Contents
Incoming Links #
Related Articles (Article 0) #
Related Medical Scholarly Articles (MedicalScholarlyArticle 1) #
- Biomarkers in triple negative breast cancer: A review
- Comprehensive molecular portraits of human breast tumours
- Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype
- The cancer genome
Related Books (Book 2) #
Related Drugs (Drug 3) #
Suggested Pages #
- 0.550 PIK3CA
- 0.038 Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
- 0.031 Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- 0.024 BRCA1
- 0.022
- 0.019 April 29
- 0.019 PCDHGA12
- 0.018 May 2
- 0.017 CIViC
- 0.017 Nature
- More suggestions...